Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 279INDUSTRY 140NIH 28OTHER_GOV 9NETWORK 2FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 49Prostatic Neoplasms 38Carcinoma, Non-Small-Cell Lung 28Neoplasms 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Multiple Myeloma 23Lymphoma 20Leukemia, Myeloid, Acute 17Colorectal Neoplasms 17Melanoma 14Lung Neoplasms 13Hodgkin Disease 11Brain Neoplasms 11Medulloblastoma 10Lymphoma, Non-Hodgkin 10HIV Infections 10Glioblastoma 10Squamous Cell Carcinoma of Head and Neck 9Pancreatic Neoplasms 9Neoplasm Metastasis 9Leukemia, Biphenotypic, Acute 9Leukemia 9Head and Neck Neoplasms 9Neuroblastoma 8Hematologic Neoplasms 8Ependymoma 8Glioma 7Carcinoma, Renal Cell 7Astrocytoma 7Sarcoma, Kaposi 6

Interventions

durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Urinary Bladder Neoplasms × 1 year × Clear all
NCT03757949 2026-05-04

Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery

SWOG Cancer Research Network

Phase 3 Active not recruiting
203 enrolled 14 charts
Genitourinary

Urinary Bladder Neoplasms

NCT03768570 2026-02-02

Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer

Canadian Cancer Trials Group

Phase 2 Active not recruiting
82 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡